Momenta Pharmaceuticals to Webcast Presentation at the 34th Annual J. P. Morgan Healthcare Conference
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler, President and CEO, will present at the 34th Annual J. P. Morgan Healthcare Conference. The presentation will be webcast on Wednesday, January 13th at 10:30 a.m. ET.
Following the presentation, management will participate in a question and answer session at 11:00 a.m. ET.
The audio webcast of the presentation and Q&A session will be available live on the “Investors” section of the company’s website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.
About MomentaMomenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
Sarah Carmody Momenta Pharmaceuticals 1-617-395-5189 [email protected]Source: Momenta Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parkland Group Announces Masterpiece Sculpture “Sacred Heart” by Jeff Koons Finds Permanent Home at Guangzhou One Pengrui
- Weekly Report (April 12-18, 2024) on the First Tranche of Stellantis 2024 Share Buyback Program
- Global Medical Isotope Market Will Grow Steadily, Driven by Increasing Demand for Nuclear Medicine Procedures
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
